EU and US could reach trade deal this weekend - Reuters
LANSING - Neogen Corporation (NASDAQ: NEOG), a global leader in food safety solutions, announced the retirement of James P. Tobin from its Board of Directors, effective May 31, 2025. Tobin has been a key figure on the board since 2016, chairing the Governance and Sustainability Committee and serving on the Audit Committee. James C. Borel, the current Chair of the Neogen Board, will assume interim leadership of the committee Tobin chaired.
The company expressed gratitude for Tobin’s contributions, highlighting his role in Neogen’s growth and transformation over his nine-year tenure. "Jim has played a key leadership role during a period of growth and transformation, helping to position the company for long-term value creation," Borel stated.
Following Tobin’s departure, Andrea Wainer will join the Neogen Board on June 1, 2025. Wainer’s appointment brings over 25 years of experience in the diagnostics and healthcare industry to Neogen’s boardroom. Her most recent role was as Executive Vice President of Rapid and Molecular Diagnostics at Abbott Laboratories. Wainer’s expertise is expected to be invaluable to Neogen’s ongoing mission and strategic direction, particularly in molecular diagnostics.According to InvestingPro data, Analog Devices, where Wainer serves as a board member, has shown remarkable financial strength with a market capitalization of $112.3 billion and consistent dividend payments for 22 consecutive years. The company maintains strong liquidity with a current ratio of 1.93 and operates with moderate debt levels.
In addition to her new role at Neogen, Wainer serves on the Board of Directors for Analog Devices, Inc. (NASDAQ: ADI), where she is part of the Nominations and Governance Committee. "Her deep expertise in molecular diagnostics, along with her strong background in finance and operational leadership, will be a tremendous asset as we continue advancing Neogen’s mission to be the leader in food safety solutions," said Borel.
Neogen Corporation, headquartered in Lansing, Michigan, is dedicated to enhancing global food security and supporting the well-being of people and animals. The company operates in over 140 countries, providing a range of solutions in Food Safety, Livestock, and Pet Health & Wellness markets. This announcement is based on a press release statement from Neogen Corporation.
In other recent news, Analog Devices has reported earnings per share of $1.63 for the January quarter, surpassing the consensus estimate of $1.54, despite a 4% decline in sales. This decline was attributed to lower performance in industrials, automotive, and communications segments, though a 19% increase in the consumer segment partially offset these decreases. In addition to earnings, shareholders of Analog Devices approved several key proposals, including the re-election of all board nominees and the ratification of Ernst & Young LLP as the independent accounting firm. Notably, a significant amendment was made to the company’s Articles of Organization, lowering the voting requirement for certain matters from a supermajority to a simple majority standard. Analyst firms have shown confidence in the company’s future, with Stifel raising the stock price target to $275 and CFRA increasing it to $265, both maintaining a Buy rating. UBS also lifted its price target to $300, citing improved industrial sector indicators and robust order strength. However, concerns over China’s tariff developments have impacted U.S.-based semiconductor manufacturers like Analog Devices, as their chips could face tariffs of 84% or higher due to their U.S. origin. Despite these challenges, the company has been recognized for shareholder-friendly actions, such as an 8% dividend increase and a new $10 billion share buyback program.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.